footer-social-menu

Sign Up for Emails

CONNECT WITH GALE

Stay up-to-date with the latest Gale news, exclusive offers, and more.

facebook

linkedin

instagram

youtube

SOCIAL ICONS

secondary-account-menu

zone2

secondary-storefront-menu

products

Marketing materials, training documents, discovery services

cengage:card

FIND YOUR SALES REPRESENTATIVE

cengage:column

Get marketing materials, training documents, discovery services.

PRODUCT SUPPORT

CUSTOMER SUPPORT

Report technical issues, errors, check system status

TECHNICAL SUPPORT

Manage product preferences, generate usage reports, simplify administrative tasks.

ADMIN TOOLS

support

Profile

Orders

Wish List

Fast Order Entry

My Account

container

cengage:galethorndikeseo

header

footer-social-menu-component

mega-menu

single-column

zone3

gale-footer

footer-legal-menu

Terms of use

Privacy

header-component

FIND YOUR REP

support-order-2

Browse by Institution Type

Browse by Product Type

Products

Support

footer-legal-menu-component

footer

secondary-primary-menu

About Us

Blogs

Press Center

Events

News

Careers

Our Company

Request a Trial

zone1

International

North America

China

Japan

Latin America

Brazil

Region

Set your region:

footer-menu-component

%1 products have been added to your cart but %2 have been backordered and will be fulfilled when stock is available

Product on backorder

Current quantity limit is [maxProductQuantity], please, navigate to the cart page and change quantity of product

You will be able to resubmit promo in ${countdown} seconds. test

Please note that the taxes displayed on our website are estimated and subject to adjustment. The actual tax charges will be determined and settled during the final invoicing of your order

product-detail-component

You may already have access to Gale content through your institution.

STUDENTS AND RESEARCHERS

support-order-1

Would you like to go to the Gale {{RECOMMENDED_COUNTRY}} site instead?

It looks like you're visiting from {{DETECTED_COUNTRY}}.

main

config

footer-menu

Academic Institutions

K-12

Public Libraries

Government and Special Libraries

Statewide Programs

Institutions

Databases

Primary Sources

Digital Humanities Tools

eLearning

Schools/K-12 Curriculum

Books

Large Print Books by Thorndike Press

Find Your Rep

Product Support

Technical Support

Customer Support

Admin Tools

Accessibility Policy

Partnerships

Contact Us

Account Information

bundle-connector

Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

HEMOGLOBIN BSD OXYGN CRRS RD CLL SUBSTTS & OXYGN THRPTC

Medical Science & Research

Health, Medicine & Nursing

Gt Product Group

Binding Format

Marketing Imprint Name

B2B GT

CL Carton Count

Imprint Name

B2B & B2C

Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions. This book will provide readers a comprehensive review of topics involved in the HBOC development. It focusses on current products and clinical applications as well as on emerging technologies and future prospects.

POST SECONDARY FOUR YEAR

COLFR

COLSO

COLJR

COLSR

Duration

Duration Unit Of Measure

Transaction Type

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Dedication Page.
Preface.
Acknowledgments.
Contents.
Contributors.
1: Introduction and Scientific Principles.
2: From Hemoglobin Based Oxygen Carrier to Oxygen Therapeutics, Blood Substitutes, Nanomedicine and Artificial Cells.
3: From the Atmosphere to the Mitochondrion: The Oxygen Cascade.
4: Biochemistry of Hemoglobin.
5: The Role of Blood and Plasma Viscosity in Restoring Oxygen Delivery Capacity.
6: Hemorrhagic Shock and Current Treatments.
7: Pathophysiology of Hemorrhagic Shock and Resuscitation.
8: Allogeneic Blood Transfusion for Surgical and Traumatic Hemorrhage.
9: Pre-Hospital Fluid Resuscitation in Civilian and Military Populations.
10: Current Issues of HBOCs and Regulatory Framework.
11: NIH/FDA/DOD Interagency Working Group on Oxygen Therapeutics.
12: Regulatory Framework for Hemoglobin-Based Oxygen Carrier Trials.
13: Approaches to HBOCs.
14: HBOCs from Chemical Modification of Hb.
15: Design of Nonhypertensive Conjugated Hemoglobins as Novel Resuscitation Fluids.
16: Cellular-Type Hemoglobin-Based Oxygen Carriers to Mimic the Red Blood Cell Structure.
17: Recombinant Octameric Hemoglobins as Resuscitation Fluids in a Murine Model of Traumatic Brain Injury Plus Hemorrhagic Shock.
18: Liposome-Encapsulated Hemoglobin as an Artificial Oxygen Carrier: Technological Features, Manufacturing and Issues for Practical Application.
19: Zero-Link Hemoglobin (Oxyvita&#x00AE;): Impact of Molecular Design Characteristics on Pre-Clinical Studies.
20: Polynitroxylated Pegylated Hemoglobin (PNPH): A Nanomedicine for Critical Care and Transfusion.
21: ATP-Adenosine-GSH Crosslinked Hb, An Oxygen Carrier with Pharmacological Properties for Multiple Therapeutic Indications.
22: Albumin-Heme Oxygen Carriers.
23: Recombinant Human Hb-SOD Fusion Proteins.
24: In-Vitro Production of Functional RBCs from Hematopoietic Stem Cells.
25: Potential Applications of HBOCs.
26: Liposome-Encapsulated Hemoglobin: Potential Clinical Applications.
27: Biocompatibility of Hemoglobin Vesicles, a Cellular-Type Artificial Oxygen Carrier, on Blood Cells and Plasma Proteins In Vitro and In Vivo.
28: Polymerized Human Placenta Hemoglobin: Organ Protective Effects and Alternative Clinical Uses.
29: Low Volume Resuscitation with HBOCs in Hemorrhagic Shock.
30: Ischemic Rescue with Hemoglobin-Based Oxygen Carriers.
31: Preclinical Evaluations of HBOCs.
32: Pre-Clinical Evaluation of Hemoglobin Based Oxygen Carriers: Animal Models and Biomarkers.
33: The Hemoglobin-Based Oxygen Carrier, HBOC-201, as a Resuscitation Fluid for Traumatic Hemorrhagic Shock: the Naval Medical Research Center Experience.
34: Cellular-Type Hemoglobin-Based Oxygen Carrier as a Resuscitative Fluid for Hemorrhagic Shock: Acute and Long-Term Safety Evaluation Using Beagle Dogs.
35: HBOC Clinical Trials.
36: Key Adverse Events in Recent HBOC Phase III Clinical Trials and Their Causal Relationship to Test HBOC&#x2019;s.
37: Some Critical Comments on the Major HBOC Clinical Trials.
38: Compassionate Use Cases Treated with Hemoglobin-Based Oxygen Carriers.
39: HBOC-Mediated Adverse Effects.
40: Acellular Hemoglobin-Based Oxygen Carrier Mediated Blood Pressure Elevation and Vasoconstriction: A Review of Proposed Mechanisms and Contributing Factors.
41: HBOCs and Cardiac Integrity.
42: Effects of Hemoglobin-Based Oxygen Carriers on Blood Coagulation.
43: Redox Activity of Cell-Free Hemoglobin: Implications for Vascular Oxidative Stress and Endothelial Dysfunction.
44: HBOC Interferences with Routine Clinical Laboratory Tests.
45: Vasoconstriction, Hypertension and Oxidative Toxicity are Regulated by Polymerized Hemoglobin Size.
46: Acellular Hemoglobin-Based Oxygen Carrier Induced Vasoactivity: A Brief Review of Potential Pharmacologic Remedies.
47: A Call for Collaborative Research and Development.
48: International Consortium for Development of Hemoglobin-Based Oxygen Carriers, Oxygen Therapeutics and Multifunctional Resuscitation Fluids&#x2013;A White Paper.

Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics.css-1p8rvzy{position:absolute;padding-left:8px;}

Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics